Acute Toxicity in High-Risk Prostate Cancer Patients Treated With Androgen Suppression and Hypofractionated Intensity-Modulated Radiotherapy-Reference-Cited by-同舟云学术

Acute Toxicity in High-Risk Prostate Cancer Patients Treated With Androgen Suppression and Hypofractionated Intensity-Modulated Radiotherapy

Published:2010-01 Issue:1 Volume:76 Page:57-64
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Pervez Nadeem,Small Cormac,MacKenzie Marc,Yee Don,Parliament Matthew,Ghosh Sunita,Mihai Alina,Amanie John,Murtha Albert,Field Colin,Murray David,Fallone Gino,Pearcey Robert

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference37 articles.

1. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007

2. Canadian Cancer Society/National Cancer Institute of Canada,2008

3. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial;Bolla;Lancet,2002

4. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The radiation therapy oncology group protocol 92-02;Hanks;J Clin Oncol,2003

5. Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial;Pollack;Int J Radiat Oncol Biol Phys,2002

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis;Clinical and Translational Radiation Oncology;2023-05

2. Prostate Cancer;Principles and Practice of Particle Therapy;2022-05-12

3. Dosimetric feasibility of moderately hypofractionated/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacer;Radiation Oncology;2022-04-01

4. Clinical Outcomes of the CHIRP Trial: A Phase II Prospective Randomized Trial of Conventionally Fractionated Versus Moderately Hypofractionated Prostate and Pelvic Nodal Radiation Therapy in Patients With High-Risk Prostate Cancer;Practical Radiation Oncology;2021-09

5. Clinical parameters and nomograms for predicting lymph node metastasis detected with 68 Ga‐PSMA‐PET/CT in prostate cancer patients candidate to definitive radiotherapy;The Prostate;2021-05-05